PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Paediatric Laboratory Medicine, CALIPER Program, The Hospital for Sick Children, Toronto, ON, Canada.\', \'Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.\', \'University Hospital of Verona, Verona, Italy.\', \'Department of Clinical Chemistry, NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW, Australia.\', \'Stellenbosch University, Cape Town, Western Cape, Republic of South Africa.\', \'DiaSys Diagnostic Systems, Holzheim, Germany.\', \'Sentinel CH. SpA, Milan, Italy.\', \'Vita-Salute San Raffaele University, Milan, Italy.\', \'Abbott Laboratories, Abbott Park, IL, USA.\', \'Department of Virology, NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW, Australia.\', \'Secretaria de Saúde do Estado de Santa Catarina, Florianópolis, Brazil.\', \'Ortho Clinical Diagnostics, Raritan, NJ, USA.\', \'Sentinel Diagnostics, Milan, Italy.\', \'National University Hospital, Singapore, Singapore.\', \'Siemens Healthcare USA, Malvern, PA, USA.\', \'University of Hong Kong, Hong Kong, P. R. China.\', \'Chinese PLA General Hospital, Beijing, P. R. China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1515/cclm-2021-0455
?:doi
?:hasPublicationType
?:journal
  • Clinical chemistry and laboratory medicine
is ?:pmid of
?:pmid
?:pmid
  • 33908222
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.114
?:rankingScore_hIndex
  • 88
?:title
  • IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all